Matwings Technology Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A2
- Investors
-
21
Matwings Technology General Information
Description
Developer of an artificial intelligence-based general protein design platform intended to provide computational chemistry for innovative drug molecular design. The company offers data-driven modeling capabilities, iterative computational refinement, experimentally anchored validation workflows, diverse engineering methodologies that adjust stability, activity, and specificity, and adaptable project support across biotechnology, diagnostics, nutrition, therapeutic development, and biomanufacturing fields, enabling engineered molecular components into their development pipelines.
Contact Information
Website
www.matwings.comCorporate Office
- 16th Floor, Building 1
- Number 58 Yuanmei Road, Minhang District
- Shanghai, 200241
- China
Corporate Office
- 16th Floor, Building 1
- Number 58 Yuanmei Road, Minhang District
- Shanghai, 200241
- China
Matwings Technology Timeline
Matwings Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC (Series A2) | 13-Jul-2026 | Completed | Generating Revenue | |||
| 8. Early Stage VC (Series A1) | 06-Feb-2026 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 31-Dec-2025 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 28-Oct-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 22-Jan-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 05-Dec-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 14-Nov-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 09-Oct-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Mar-2022 | Completed | Startup |
Matwings Technology Patents
Matwings Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026183933-A1 | Esterase variant and use thereof | Pending | 03-Mar-2025 | ||
| WO-2025251417-A1 | Thermostable mutant of t7 rna polymerase and use of thermostable mutant | Pending | 03-Jun-2024 |
Matwings Technology Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Golden Vision Capital | Family Office | Minority | ||
| Hunan Caixin Investment Holding Group | Government | Minority | ||
| Jiangsu Jujie Microfiber Technology Group | Corporation | Minority | ||
| SDIC Innovation Investment Management | Asset Manager | Minority | ||
| Shanghai Guotou Pioneer Private Equity Fund Management | Fund of Funds | Minority |
Matwings Technology Investments (2)
Matwings Technology’s most recent deal was a Early Stage VC with Lightsyn. The deal was made on 15-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Lightsyn | 15-Jun-2025 | Early Stage VC | Biotechnology | ||
| Feiyinke Biotechnology | 16-Jan-2023 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology |
Matwings Technology FAQs
-
When was Matwings Technology founded?
Matwings Technology was founded in 2021.
-
Where is Matwings Technology headquartered?
Matwings Technology is headquartered in Shanghai, China.
-
What industry is Matwings Technology in?
Matwings Technology’s primary industry is Discovery Tools (Healthcare).
-
Is Matwings Technology a private or public company?
Matwings Technology is a Private company.
-
What is Matwings Technology’s current revenue?
The current revenue for Matwings Technology is .
-
How much funding has Matwings Technology raised over time?
Matwings Technology has raised $24.8M.
-
Who are Matwings Technology’s investors?
Golden Vision Capital, Hunan Caixin Investment Holding Group, Jiangsu Jujie Microfiber Technology Group, SDIC Innovation Investment Management, and Shanghai Guotou Pioneer Private Equity Fund Management are 5 of 21 investors who have invested in Matwings Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process